Exhibit 99.1
| October 10, 2025 | |
Filed via SEDAR+
To All Applicable Exchanges and Securities Administrators
| Subject: | InMed Pharmaceuticals Inc. (the “Issuer”) |
| Notice of Meeting and Record Date |
Dear Sir/Madam:
We are pleased to confirm the following information with respect to the Issuer’s upcoming meeting of securityholders:
| Meeting Type: | Annual General and Special Meeting |
| Meeting Date: | December 17, 2025 |
| Record Date for Notice of Meeting: | October 22, 2025 |
| Record Date for Voting (if applicable): | October 22, 2025 |
| Beneficial Ownership Determination Date: | October 22, 2025 |
| Class of Securities Entitled to Vote: | Common Shares |
| ISIN: | CA4576377002 |
| Issuer sending proxy materials directly to NOBOs: | No |
| Issuer paying for delivery to OBOs: | No |
| Notice and Access for Beneficial Holders: | Yes |
| Notice and Access for Registered Holders: | Yes |
In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.
Yours truly,
Odyssey Trust Company
as agent for InMed Pharmaceuticals Inc.